×

Health Care Equipment and Supplies Health Care Equipment

  • NEW YORK, Nov 16- A federal jury in Dallas on Thursday ordered Johnson& Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants. Six New York residents implanted with the devices said they experienced tissue death, bone erosion and other injuries they blamed on design flaws.

  • The da Vinci robotic system.

    Goldman Sachs reiterates its buy rating for Intuitive Surgical shares, predicting the company will report earnings above expectations next year.

  • NEW YORK, Nov 16- A federal jury in Dallas on Thursday ordered Johnson& Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants. Six New York residents implanted with the hip devices said they experienced tissue death, bone erosion and other injuries they blamed on design flaws.

  • NEW YORK, Nov 16- A federal jury in Dallas on Thursday ordered Johnson& Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants. The jury found that the metal-on-metal hip implants were defectively designed and that the companies failed to warn consumers about the risks.

  • WASHINGTON— U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns. But developers Otsuka Pharmaceutical Co. and Proteus Digital Health are likely to face hurdles. "It's truth serum time," said Arthur Caplan, a medical ethicist...

  • A registered nurse hangs an I.V. bag for a patient at the University of Miami Hospital's Emergency Department.

    JPMorgan health care expert Lisa Gill shared her views on the impact Amazon is having on the pharmaceutical space.

  • PRO Talks: Lisa Gill

    JPMorgan health care expert Lisa Gill shared her thoughts on the hotly-followed drug pricing debate as well as potential stock picks.

  • This device records the tremors of patients with Parkinson's disease and mimics them on other people.

  • This device records the tremors of patients with Parkinson's disease and mimics them on other people.

  • Boston Scientific said sales of pacemakers dipped 4.5 percent to $149 million in the quarter ended Sept. 30. The result fell $6.5 million short of Wall Street estimates, according to analysts at JPMorgan. Marlborough, Massachusetts- based Boston Scientific said its total net sales rose 5.6 percent to $2.22 billion, edging past analysts' average estimate of...

  • Oct 26- U.S. medical device maker Boston Scientific Corp's profit rose 24 percent in the third quarter, driven by growth across all its businesses. The company said on Thursday its net profit climbed to $283 million or 20 cents per share in the quarter ended Sept. 30, from $228 million or 17 cents per share, a year earlier. Net sales rose 5.6 percent to $2.22 billion.

  • The U.S. regulator in July issued Meridian's unit, Magellan Diagnostics, a Form 483 for its North Billerica, Massachusetts- based facility, nearly two months after it warned that the tests may underestimate lead levels in blood. Magellan's devices are the only lead-testing products cleared by the FDA and account for about half of all lead tests in the United...

  • The U.S. regulator in July issued Meridian's unit, Magellan Diagnostics, a Form 483 for its North Billerica, Massachusetts- based facility, nearly two months after it warned that the tests may underestimate lead levels in blood. Magellan's devices are the only lead-testing products cleared by the FDA and account for about half of all lead tests in the United...

  • Oct 23- The U.S. Food and Drug Administration said on Monday it issued a warning letter to Meridian Bioscience Inc's unit for several federal law violations after inspecting its facility that makes lead-testing devices. In July, the U.S. regulator raised concerns about Meridian's facility that makes the devices, nearly two months after the FDA warned that the...

  • Oct 20- The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies in Puerto Rico to prevent shortages of medical products in the United States as it joins a massive effort to help rebuild the island that was ravaged by Hurricane Maria. FDA Commissioner Scott Gottlieb said the agency...

  • Jude Medical and Alere, to bolster its medical devices business, and favorable tax laws in India are boosting its generics business. The company's shares rose 2.8 percent to $56.60 to a record in morning trading. Sales in the medical devices business rose 6.5 percent to $2.60 billion, accounting for more than a third of total sales.

  • Abbott forecast full-year adjusted 2017 profit from continuing operations of $2.48- $2.50 per share. It had earlier expected earnings per share of $2.43- $2.53. Several devices received U.S. Food and Drug Administration approvals in the quarter, including Abbott's FreeStyle Libre glucose monitoring system and two of its heart devices- HeartMate 3 and...

  • Jude Medical acquisition, with sales rising 6.5 percent to $2.60 billion in the third quarter ended Sept. 30. Net sales rose to $6.83 billion from $5.30 billion. Net earnings rose to $603 million, or 34 cents per share, in the quarter, from a loss of $329 million, or 22 cents per share, a year earlier.

  • OrthoPediatrics celebrates initial public offering by ringing Friday's opening bell at the Nasdaq MarketSite.

  • The Johnson & Johnson logo

    Johnson & Johnson notched its second upgrade this week after Jefferies raised its rating to buy from hold.